Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN

Clinical Journal of the American Society of Nephrology

Volumn 8, Issue 11, 2013, Pages 1884-1891

  Gou, Shen Ju ^a   Yuan, Jun ^a   Wang, Chen ^a   Zhao, Ming Hui ^a   Chen, Min ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT ALTERNATIVE PATHWAY ACTIVATION PRODUCT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATINE KINASE BB; CREATININE; MANNOSE BINDING LECTIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; ATROPHY; CLINICAL ARTICLE; COMPLEMENT DEPOSITION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; GLOMERULONEPHRITIS; GLOMERULUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PROTEIN URINE LEVEL; SLEDAI; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CHINA; COMPLEMENT FACTOR B; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; URINALYSIS; YOUNG ADULT;

EID: 84887273005     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02790313     Document Type: Article

References (28)

1. Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant 8: 696-702, 1993
2. Falk RJ, Jennette JC: ANCA small-vessel vasculitis. J Am Soc Nephrol 8: 314-322, 1997
3. Van Timmeren MM, Chen M, Heeringa P: Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis. Nephrology (Carlton) 14: 16-25, 2009
4. Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M: New insights of an old defense system: Structure, function, and clinical relevance of the complement system. Mol Med 17: 317-329, 2011
5. Cuellar ML, Espinoza LR: Laboratory testing in the evaluation and diagnosis of vasculitis. Curr Rheumatol Rep 2: 417-422, 2000
6. Huugen D, van Esch A, XiaoH, Peutz-Kootstra CJ, BuurmanWA, Tervaert JW, Jennette JC, Heeringa P: Inhibition of complement factor C5 protects against anti-myeloperoxidase antibodymediated glomerulonephritis in mice. Kidney Int 71: 646-654, 2007
7. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC: Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170: 52-64, 2007
8. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R: C5a receptor mediates neutrophil activation and ANCAinduced glomerulonephritis. J Am Soc Nephrol 20: 289-298, 2009
9. Hao J, Meng LQ, Xu PC, ChenM, Zhao MH: p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation. PLoS ONE 7: e38317, 2012
10. Hao J, Chen M, Zhao MH: Involvement of protein kinase C in C5a-primed neutrophils for ANCA-mediated activation. Mol Immunol 54: 68-73, 2013
11. Yuan J, Chen M, Zhao MH: Complement in antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Nephrol, in press
12. Chen M, Xing GQ, Yu F, Liu G, Zhao MH: Complement deposition in renal histopathology of patients with ANCA-associated pauci-immune glomerulonephritis. Nephrol Dial Transplant 24: 1247-1252, 2009
13. Yuan J, Gou SJ, Huang J, Hao J, Chen M, Zhao MH: C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Arthritis Res Ther 14: R140, 2012
14. Xing GQ, Chen M, Liu G, Heeringa P, Zhang JJ, Zheng X, e J, Kallenberg CG, Zhao MH: Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis. J Clin Immunol 29: 282-291, 2009
15. Gou SJ, Yuan J, ChenM, Yu F, Zhao MH: Circulating complement activation in patients with anti-neutrophil cytoplasmic antibodyassociated vasculitis. Kidney Int 83: 129-137, 2013
16. Hellmich B, Flossmann O, Gross WL, Bacon P, Cohen-Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott DG, Witter J, Yazici H, Luqmani RA: EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on anti-neutrophil cytoplasmantibody-associated vasculitis. Ann Rheum Dis 66: 605-617, 2007
17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, Mccluskey RT, Singh RA, Rees AJ, Van LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994
18. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M: The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15: 241-250, 2004
19. HochbergMC:Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725, 1997
20. Bajema IM, Hagen EC, Hansen BE, Hermans J, Noël LH, Waldherr R, Ferrario F, van der Woude FJ, Bruijn JA: The renal histopathology in systemic vasculitis: An international survey study of inter-and intra-observer agreement. Nephrol Dial Transplant 11: 1989-1995, 1996
21. Bajema IM, Hagen EC, Hermans J, Noël LH, Waldherr R, Ferrario F, Van Der Woude FJ, Bruijn JA: Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56: 1751-1758, 1999
22. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC; European Vasculitis Study Group (EUVAS): Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int 61: 80-89, 2002
23. Sahu A, Lambris JD: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180: 35-48, 2001
24. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, Savage C, AduD: BirminghamVasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671-678, 1994
25. Gullstrand B, Martensson U, Sturfelt G, Bengtsson AA, Truedsson L: Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 156: 303-311, 2009
26. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM: C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194: 781-795, 2001
27. Morita Y, Nomura A, Yuzawa Y, Nishikawa K, HottaN, Shimizu F, Matsuo S: The role of complement in the pathogenesis of tubulointerstitial lesions in rat mesangial proliferative glomerulonephritis. J Am Soc Nephrol 8: 1363-1372, 1997
28. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S: Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 11: 700-707, 2000